8-K filed April 8, 2025, 7:59 PM ET ticker AWHL CIK 0000926617

other material confidence high sentiment negative materiality 0.70

Aspira Women's Health raises up to $2M via discounted equity; appoints three new directors

Aspira Women's Health Inc.

Equity purchase agreement with Triton Funds for up to $2M; first tranche 354,988 shares for $25,000.
Subsequent purchases priced at 75% of lowest 5-day trading price before closing.
Proceeds for commercial activities and working capital; subject to Nasdaq 19.99% limitation.
Appointed new directors: Dr. Jeffrey Cohen, John Fraser, Cynthia Hundorfean (eff. Apr 2-6, 2025).
Julie Carrillo appointed interim Principal Accounting Officer; Dr. Celeste Fralick departed Board.

item 1.01 item 3.02 item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Cynthia Hundorfean

director

AWHL · Aspira Women's Health Inc.

Effective: 2025-04-06
Filed: April 8, 2025, 7:59 PM ET

On April 6, 2025, the Board appointed John Fraser and Cynthia Hundorfean as directors of the Company.

Appointed

John Fraser

director

AWHL · Aspira Women's Health Inc.

Effective: 2025-04-06
Filed: April 8, 2025, 7:59 PM ET

On April 6, 2025, the Board appointed John Fraser and Cynthia Hundorfean as directors of the Company.

Appointed

Jeffrey Cohen

director

AWHL · Aspira Women's Health Inc.

Effective: 2025-04-02
Filed: April 8, 2025, 7:59 PM ET

On April 2, 2025, the Board (the “Board”) of Directors of the Company appointed Jeffrey Cohen, M.D. as a director of the Company.

Appointed (interim)

Julie Carrillo

Principal Accounting Officer

AWHL · Aspira Women's Health Inc.

Effective: 2025-04-04
Filed: April 8, 2025, 7:59 PM ET

On April 4, 2025, the Board appointed Julie Carrillo, the Company’s Corporate Controller, to act as the Principal Accounting Officer of the Company on an interim basis.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Cynthia Hundorfean was appointed as director at Aspira Women's Health Inc..

Action: appointed
Role: director

Exact text from the filing

On April 6, 2025, the Board appointed John Fraser and Cynthia Hundorfean as directors of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

John Fraser was appointed as director at Aspira Women's Health Inc..

Action: appointed
Role: director

Exact text from the filing

On April 6, 2025, the Board appointed John Fraser and Cynthia Hundorfean as directors of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey Cohen was appointed as director at Aspira Women's Health Inc..

Action: appointed
Role: director

Exact text from the filing

On April 2, 2025, the Board (the “Board”) of Directors of the Company appointed Jeffrey Cohen, M.D. as a director of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Julie Carrillo was appointed as Principal Accounting Officer at Aspira Women's Health Inc..

Action: appointed
Role: Principal Accounting Officer

Exact text from the filing

On April 4, 2025, the Board appointed Julie Carrillo, the Company’s Corporate Controller, to act as the Principal Accounting Officer of the Company on an interim basis.

View on SEC.gov

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-003135

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.